Ion Beam Ownership
| IOBCF Stock | USD 13.58 0.47 3.35% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Ion |
Ion Pink Sheet Ownership Analysis
About 29.0% of the company shares are held by company insiders. The book value of Ion Beam was currently reported as 3.34. The company last dividend was issued on the 29th of June 2022. Ion Beam Applications had 1021:1000 split on the 13th of January 2000. Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium. ION Beam operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1668 people.The quote for Ion Beam Applications is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Ion Beam Applications call Olivier Legrain at 32 1 047 58 11 or check out https://www.iba-worldwide.com.Currently Active Assets on Macroaxis
Other Information on Investing in Ion Pink Sheet
Ion Beam financial ratios help investors to determine whether Ion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ion with respect to the benefits of owning Ion Beam security.